Skip to main content
. 2020 Nov 7;78(2):1–9. doi: 10.1001/jamaneurol.2020.4396

Figure 1. Kaplan-Meier Event Curves for the Primary Efficacy End Point (Stroke or Death) in Patients With a 30-Day Modified Rankin Scale Score (mRS) Greater Than 1 and With a 30-Day mRS 0 to 1.

Figure 1.